CompletedNot Applicable

PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms

United States700 participantsStarted 2020-09-15

Plain-language summary

The aim of this study is to use a validated patient-reported outcome measure to evaluate how many patients have symptoms of pancreatitis after ERCP and how it correlates with their quality of life and productivity.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients undergoing ERCP
✓. Age \>= 18 years old
✓. Intact major papilla

Exclusion criteria

✕. Unwillingness or inability to consent for the study
✕. Age \< 18 years
✕. Standard contraindications to ERCP
✕. Intrauterine pregnancy
✕. Prior hepaticojejunostomy in a patient undergoing ERCP for a bile duct indication
✕. Prior pancreaticojejunostomy in a patient undergoing ERCP for a pancreatic duct indication
✕. Low probability of completing the follow-up
✕. Acute pancreatitis (by the Revised Atlanta criteria) in the seven days prior to ERCP.

What they're measuring

Post-ERCP Pancreatitis

Timeframe: 7 days after ERCP

PROM-PEP

Timeframe: 30 days

Trial details

NCT IDNCT05310409

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-08-01

View on ClinicalTrials.gov More Post-ERCP Acute Pancreatitis trials